semaglutide week by week JOURNEY *week 3* // Feeling amazing, back into strength training + down 10 lbs! Peptide Therapy Semaglutide for Weight
Description
Persistent lymphadenopathy (3 weeks for neck lumps) requires GP assessment and may warrant suspected cancer pathway referral per NICE NG12

Drawing days in advance creates contamination and stability risks

2 Exhibit 1: US market penetration vs projected market size In the most recent wave of developments, Novo secured an FDA label expansion for Wegovy for cardiovascular risk reduction (a key step toward medicalizing reimbursement beyond cosmetic weight loss) and, importantly for premiumization, also announced approval of a once-daily oral Wegovy option potentially widening adoption among injectionaverse patients while intensifying competition in convenience-led segments

We also show that GLP-1 inhibits inflammatory pathways in the LPS-induced RAW264.7 cells

FDA approval for retatrutide is projected for late next year, with commercial launch expected in early the year after

Fatigue: Some patients experience tiredness, particularly initially
